TITLE:
A Study of Avastin With Chemotherapy for Treatment of Metastatic or Advanced and Unresectable Colorectal Adenocarcinoma

CONDITION:
Colorectal Cancer

INTERVENTION:
NONE

SUMMARY:

      This is an observational study designed to follow patients with metastatic or locally
      advanced and unresectable colorectal cancer who are receiving Avastin in combination with
      chemotherapy and whose cancer has been either previously untreated or treated <=4 months
      prior to enrollment.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: N/A to N/A
Criteria:

        Inclusion Criteria:

          -  Signed Informed Consent and Authorization document

          -  Metastatic, or locally advanced and unresectable, adenocarcinoma of the colon or
             rectum

          -  Receiving Avastin as a component of first-line chemotherapy

          -  First-line chemotherapy plus Avastin initiated <=4 months prior to enrollment in the
             study

        Exclusion Criteria:

          -  Patients who have contraindications for treatment with Avastin (see the Avastin
             Package Insert) or who would incur excessive risks with Avastin treatment are
             ineligible for this study.
      
